MedPath

ORAL VERSUS VAGINAL MISOPROSTOL FOR INDUCTION OF LABOUR IN UNIVERSITY OF MAIDUGURI TEACHING HOSPITAL. A RANDOMISED CONTROLLED TRIA

Phase 2
Recruiting
Conditions
Pregnancy and Childbirth
Registration Number
PACTR202401578504771
Lead Sponsor
Maduka Chike Joachim
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
100
Inclusion Criteria

The following inclusion criteria will be applied:
1)All booked pregnant women who are planned for induction of labour at term with singleton pregnancy presenting cephalic and with favourable cervix (Bishop score of =6).
2)Patients that are informed, counseled, and consented to participate in the study.
3)Patients that is para 0 to 4.
4)No known contraindications to misoprostol

Exclusion Criteria

The following criterial will be excluded
1)Previous uterine scar and/or malpresentation
2)Antepartum heamorrhage.
3)Patients with intrauterine fetal death, HIV, active hepatitis B infection
4)Patients refusal to consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome will be incidence of vaginal delivery in both arms
Secondary Outcome Measures
NameTimeMethod
secondary outcomes will be induction-delivery interval, fetal heart abnormalities (tachycardia, bradycardia), maternal satisfaction, adverse effects of misoprostol fever, shivering, nausea, vomiting, and diarrhoea, Apgar score at fifth minute, and number of caesarean sections in both arms.
© Copyright 2025. All Rights Reserved by MedPath